CM-272

N/A

Report date: 2024/11/05 16:40:42
NME

Base Information

Drug NameCM-272
Drug Alias NameCM-272
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitorsHistone-lysine N-methyltransferase EHMT2 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1Histone-lysine N-methyltransferase EHMT2
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Navarra
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Navarra
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A